SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-018909
Filing Date
2024-05-13
Accepted
2024-05-13 16:31:07
Documents
42
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 595966
2 ex31-1.htm EX-31.1 17670
3 ex31-2.htm EX-31.2 17556
4 ex32-1.htm EX-32.1 4487
  Complete submission text file 0001493152-24-018909.txt   2418165

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE telo-20240331.xsd EX-101.SCH 18741
6 XBRL CALCULATION FILE telo-20240331_cal.xml EX-101.CAL 27339
7 XBRL DEFINITION FILE telo-20240331_def.xml EX-101.DEF 64250
8 XBRL LABEL FILE telo-20240331_lab.xml EX-101.LAB 155771
9 XBRL PRESENTATION FILE telo-20240331_pre.xml EX-101.PRE 127152
45 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 213670
Mailing Address 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606
Business Address 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606 (813) 864-2562
Telomir Pharmaceuticals, Inc. (Filer) CIK: 0001971532 (see all company filings)

IRS No.: 872606031 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41952 | Film No.: 24939606
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)